The Clorox Company has launched Clorox™ PURE™ Allergen Neutralizer, marking its entry into the air care category. Unveiled January 13, 2026, the line includes daily air and fabric sprays designed to neutralize non-living pollen, dust mite matter and pet dander before they trigger allergic reactions. Powered by a plant-based active ingredient and proprietary Aller-Fresh™ Technology, the sprays alter allergen protein structures to prevent binding to human receptors. Available in four allergen-free fragrances—Clean Breeze, Ocean Mist, Nighttime Calm and Energizing Citrus—the products aim to integrate into daily routines without requiring lifestyle changes. Retail distribution has begun at major outlets including Walmart and Amazon, supporting Clorox’s strategic move to broaden its wellness-focused portfolio beyond traditional surface cleaning solutions.

Analyst coverage of The Clorox Company remains cautious, with nineteen brokerages assigning an average recommendation of “Reduce.” Four analysts maintain sell ratings, fourteen are neutral, and one issues a buy. Recent reports reflect downward revisions of implied valuations: Goldman Sachs and Barclays both lowered their price targets, while Citigroup and Deutsche Bank trimmed theirs based on slower top-line growth. On the insider front, director Pierre R. Breber increased his stake by 44% through a purchase of 4,000 shares in November, bringing his ownership to 13,000 shares. Institutional ownership stands at nearly 79%, with notable position increases by Mirae Asset Global ETFs, Woodline Partners LP and Focus Partners Wealth during the first quarter, signaling that while analysts express caution, certain investors are accumulating shares for the long term.